JPS62145027A - Fermented food - Google Patents

Fermented food

Info

Publication number
JPS62145027A
JPS62145027A JP60284211A JP28421185A JPS62145027A JP S62145027 A JPS62145027 A JP S62145027A JP 60284211 A JP60284211 A JP 60284211A JP 28421185 A JP28421185 A JP 28421185A JP S62145027 A JPS62145027 A JP S62145027A
Authority
JP
Japan
Prior art keywords
food
foods
genus
diseases
fermented food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60284211A
Other languages
Japanese (ja)
Inventor
Tsutomu Tamura
田村 力
Toshio Takahashi
敏雄 高橋
Satoshi Matsuda
聡 松田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP60284211A priority Critical patent/JPS62145027A/en
Publication of JPS62145027A publication Critical patent/JPS62145027A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Beans For Foods Or Fodder (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide a fermented food effective in improving the condition of diseases such as hypertention, cardiac diseases, etc., composed of basidiomycete of Fomes genus, cereals or potatoes as a carbon source and beans as a nitrogen source and containing beta-D-glucan, saponin and ergosterol. CONSTITUTION:The objective fermented food can be produced e.g. by culturing basidiomycete belonging to Fomes genus in a liquid medium containing cereals or potatoes as a carbon source and beans as a nitrogen source. The fermented food contains beta-D-glucan having pharmacological activity such as carcinostatic activity, a saponin having anticomplementary activity and antioxidation action, etc., and ergosterol having diuretic action, etc. The effect of the food to improve the condition of diseases is comparable or superior to that of the fruit body of basidiomycete of Fomes genus. It contains various nutrients in balanced and easily absorbable state and is suitable for special nutrient food and medical food. The food is expected to have the effect to improve the condition of cardiac diseases and cerebrovascular disorder, etc.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、病態改善に供せられる発酵食品に関するもの
である。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to fermented foods that can be used to improve pathological conditions.

(従来の技術) 近年、日本人の食生活が欧米化し、各種加工食品の導入
と高力cr 17−食および高脂肪食の摂取による過食
、飽食が原因で健康が害され、食が原因の各種疾病が増
大している。
(Prior art) In recent years, the eating habits of Japanese people have become Westernized, and with the introduction of various processed foods, overeating and overeating due to the intake of high-strength CR17-foods and high-fat foods have led to health problems, and food-related causes have become more prevalent. Various diseases are increasing.

見かけは長寿で健康そうであるが、人々の健康は徐々に
むしばまれ、高血圧、糖尿病、心臓病などの成人病が静
かに進行している。また、高置化による血管障害等によ
って循環器系の失調が体力年令の低下をきたし老化を促
進している。
Although people appear to be living long and healthy lives, their health is gradually being eroded, and adult diseases such as high blood pressure, diabetes, and heart disease are quietly progressing. In addition, circulatory system disorders due to vascular disorders and other factors caused by high elevations lead to a decline in physical strength and accelerate aging.

このような重大な問題を各種疾患Ω予防および改善とい
う目的で、医薬品としてでなく、食の面からとりあげて
解決しようとする試みも種々なされている。例えば、「
栄養改善法」に定められている「特殊栄養食品」や「健
康保険法」に定められている「医療用食品」あるいはい
わゆる「健康食品」等である。
Various attempts have been made to solve such serious problems from the viewpoint of food rather than medicine, with the aim of preventing and improving various diseases. for example,"
These include ``special nutritional foods'' stipulated in the ``Nutrition Improvement Act'' and ``medical foods'' or so-called ``health foods'' stipulated in the ``Health Insurance Law.''

「栄養改善法」は、「国民の栄養改善思想を高め、国民
の栄養状態を明らかにし、かつ国民の栄養を改善する方
途を講じて国民の健康および体力の維持向上を図り、も
って国民の福祉の増進に寄与すること」を目的としてい
る(栄養改善思想1条)。特殊栄養食品には、ビタミン
強化米等の各種強化食品(米、小麦粉、食パン等)や、
低ナトリウム食品、低カロリー食品、低蛋白質食品、高
蛋白質食品等がある。
The ``Nutrition Improvement Act'' aims to ``enhance the people's idea of improving nutrition, clarify the nutritional status of the people, and take measures to improve the people's nutrition to maintain and improve the health and physical strength of the people, thereby contributing to the welfare of the people.'' (Article 1 of Nutrition Improvement Philosophy). Special nutritional foods include various fortified foods (rice, flour, white bread, etc.) such as vitamin-enriched rice,
There are low sodium foods, low calorie foods, low protein foods, high protein foods, etc.

「医療用食品」は、厚生省告示では「主とじて入院患者
の給食用に用いられることを目的とする食品であって調
理加工後の栄養成分が分析されていてかつ当該栄養成分
分析値が保たれている食品」と定義づけられている。例
えば、ノ・ンバーグ、いわしフライ、ミートエラグ等の
食品である。
According to the Ministry of Health and Welfare notification, "medical food" is defined as "food that is primarily intended to be used as a meal for hospitalized patients, whose nutritional components have been analyzed after cooking and processing, and whose nutritional component analysis values have been maintained." It is defined as "food that has been sagging". For example, foods such as nonburger, fried sardines, and meat elag.

いわゆる「健康食品」には、植吻・動物性原料の抽出物
や、ビタミン剤、ミネラル剤等がある。
So-called "health foods" include extracts of proboscis and animal raw materials, vitamin supplements, mineral supplements, etc.

これらは、特定の栄養素による栄養補助や、健康増進や
、肥満防止等をうたっている。抽出物を用いた例には、
アマチャヅルから抽出されたアマチャヅル粗サポニン成
分および/またはレイシの抽出物を必須成分としてなる
「抗アレルギー食品」がある(特開昭60−11415
4号公報)。また、「マンネンタケエキスを有効成分と
する健康食品」(特開昭60−43356号公報)や、
「マンネンタケ培養菌糸体健康食品」(特開昭60−4
5557号公報)もある。他に、豆類と野菜類訃よび穀
類とを組合わせた素材を用いて、エノキタケを始めとす
るシイタケ以外の食用茸の菌糸を培養して得られる発酵
食品も知られている(特開昭60−188042号公報
)。
These products claim to provide nutritional support through specific nutrients, promote health, and prevent obesity. Examples using extracts include:
There is an "anti-allergic food" which contains as essential ingredients a crude saponin component of Jiaogulan extracted from Jiaogulan and/or an extract of Reishi (Japanese Patent Application Laid-open No. 11415-1983).
Publication No. 4). In addition, ``Health food containing pine mushroom extract as an active ingredient'' (Japanese Unexamined Patent Publication No. 60-43356),
“Healthy food made from cultured mycelium of C. chinensis”
No. 5557) is also available. In addition, fermented foods are also known that are obtained by culturing the mycelium of edible mushrooms other than shiitake, including enokitake, using a combination of beans, vegetable matter, and grains (Japanese Patent Laid-Open No. 1983-1993). -188042).

(発明が解決しようとする問題点) 従来の「特殊栄養食品」、例えば、減塩醤油や減塩味@
等は、高血圧や腎臓疾7轡、心臓疾患患者など医師にナ
トリウム、食塩の摂取量の制限を指示された場合に限り
、医師、栄養士等の相談、指導を得て使用する必要があ
るものである。また、ビタミン強化米等の各種強化食品
や低ナトリウム食品、低カロリー食品、低蛋白質食品、
高蛋白質食品等は、特定の栄養成分の減少あるいは補強
を行なっただけのものであり、多量にこれらの食品を摂
取することにより、各種の弊害が発生することもある。
(Problems to be solved by the invention) Conventional "special nutritional foods" such as low-salt soy sauce and low-salt flavors @
etc., should be used only in patients with high blood pressure, kidney disease, heart disease, etc. who have been instructed by a doctor to limit their intake of sodium and salt, and with the consultation and guidance of a doctor, nutritionist, etc. be. In addition, various fortified foods such as vitamin-enriched rice, low-sodium foods, low-calorie foods, low-protein foods,
High-protein foods and the like are simply foods with reduced or reinforced specific nutritional components, and ingesting large amounts of these foods may cause various adverse effects.

すなわち、疾病の原因と々る成分の増減により、疾病の
進行を止めているだけであって、積極的な病態改善効果
を目的としていない。また、単一食品であるので栄養バ
ランスも整っておらず、食生活改善や健康維持、体力向
上を目的とし7’rす、病気に効くと誤解したりして、
多量に使用する場合は、むしろ疾病を促進する恐れも十
分ある。
In other words, it merely stops the progression of the disease by increasing or decreasing the components that cause the disease, and is not intended to actively improve the disease condition. In addition, since it is a single food, it is not nutritionally balanced, and while it is intended to improve eating habits, maintain health, and improve physical strength, people sometimes misunderstand that it is effective against diseases.
If used in large quantities, there is a strong possibility that it may actually promote disease.

従来の「医療用食品」も単一食品であり、食事全体の栄
養バランスをとろうとすると、栄養士が個々の食品の栄
養素および栄養tを考慮して組合わせを考え献立を作成
する必要がある。また、「医療用食品」は給食の向上を
図るための、調理後の栄養水率が保証された加工食品で
あるので、特定の栄養成分を補強したり、あるいは減少
したりしたものでもない。個々の食品について考えると
、栄養学的にバランスが考えられているものでなく、食
事療法の一素材として使うことはできても、それを摂取
することによって疾病が改善されるというものではない
。すなわち、病態改善効果については全く考慮されてい
ない。
Conventional "medical foods" are also single foods, and in order to achieve a nutritionally balanced diet as a whole, it is necessary for a dietitian to consider combinations and create a menu, taking into account the nutrients and nutrients of each individual food. In addition, "medical food" is a processed food that guarantees a nutrient water content after cooking in order to improve school lunches, so it does not have specific nutritional components reinforced or reduced. When we think about individual foods, they are not nutritionally balanced, and although they can be used as ingredients for dietary therapy, consuming them does not mean that diseases will be improved. That is, no consideration is given to the effect of improving pathological conditions.

いわゆる南東食品」は、成分のはつきシしないものが多
く、病態改善効果を示唆するような表示をしているもの
でさえも病態改善効果のある有効成分の存在は不明であ
り、病態改善効果も不明確である。成分分析を行なって
いるような「健康食品」でも、日常、食する食品として
の栄養バランスや病態改善効果をもつ有効成分の含有量
および品質の安定性に疑問をいだかせるものが多い。例
えば、アマチャヅルから抽出されたアマチャヅル粗サポ
ニン成分および/またはレイシの抽出物を必須成分とし
てなる「抗アレルギー食品」 (%開昭60−1141
54号公報)Fi、アマチャヅル粗サポニンとレイシの
抽出物とを、それぞれ単独あるいは混合物として含有す
る食品である。アマチャヅル粗サポニンおよび/または
レイシ抽出物が含有されているので、それぞれの薬理効
果は示唆されるが、病態改善に必要な他の栄養成分およ
び栄養バランスは不明であり、考慮されていない。
Many of the so-called "Southeast foods" do not have clear ingredients, and even if they are labeled as suggesting that they have an effect on improving disease conditions, the existence of active ingredients that have an effect on improving disease conditions is unknown. is also unclear. Even for ``health foods'' whose ingredients have been analyzed, there are many that raise questions about the nutritional balance of foods that can be eaten on a daily basis, the content of active ingredients that have the effect of improving disease conditions, and the stability of quality. For example, "anti-allergic food" (%Kasho 60-1141
No. 54) Fi, a food containing Jiaogulan crude saponin and Reishi extract, either alone or as a mixture. Since it contains crude Jiaogulan saponin and/or Ganoderma extract, the pharmacological effects of each are suggested, but the other nutritional components and nutritional balance necessary for improving the disease condition are unknown and have not been taken into account.

また、「マンネンタケエキスを有効成分とする健康食品
」(特開昭60−43356号公報、)は、グルコース
および小麦胚芽を必須成分とする液体培地中でマンネン
タケ菌糸体を培養して得られる培養物またはそれから分
離した菌糸体の抽出エキス、あるいは菌糸体を分離した
培養液の濃縮物を有効成分としてなる健康食品である。
In addition, "Health food containing C. chinensis extract as an active ingredient" (Japanese Patent Application Laid-Open No. 60-43356) is a culture obtained by culturing C. cinnabar mycelium in a liquid medium containing glucose and wheat germ as essential ingredients. Alternatively, it is a health food containing an extract of the mycelium separated therefrom, or a concentrate of the culture solution from which the mycelium is separated as an active ingredient.

これもマンネンタケの薬理効果は示唆されるが、病態改
善に必要な他の栄養成分および栄養バランスは不明であ
り、考慮されていない。
Although this also suggests the pharmacological effects of Cinnamon mushroom, the other nutritional components and nutritional balance necessary for improving the disease condition are unknown and have not been taken into account.

また、「マンネンタケ培養菌糸体健康食品」(特開昭6
0−45557号公報)は、グルコースおよび小麦胚芽
を必須成分とする液体培地中で培養して得られるマンネ
ンタケ菌糸体からなる健康食品である。これもマンネン
タケの薬理効果は示唆されるが、病態改善に必要な他の
栄着成分および栄養バランスは不明であり、考慮されて
いない。
In addition, "Healthy food made from cultured mycelium of Rockfish" (Unexamined Japanese Patent Publication No. 6)
No. 0-45557) is a health food consisting of C. chinensis mycelium obtained by culturing it in a liquid medium containing glucose and wheat germ as essential components. Although this also suggests the pharmacological effects of Cinnamon mushroom, the other nourishing ingredients and nutritional balance necessary for improving pathological conditions are unknown and have not been taken into account.

その他の例として、豆類と野菜類および穀類とを組合わ
せた素材を用いて、エノキタケを始めとするシイタケ以
外の食用茸の菌糸を培養して得られる発酵食品(%開昭
60−188042号公報)があるが、この食品は、栄
養成分の含有という点で問題にないが、いわゆる「健康
食品」的なものであり、病態改善の効果は期待できない
Another example is a fermented food obtained by culturing the mycelium of edible mushrooms other than shiitake, including enokitake, using a combination of beans, vegetables, and grains. ), although this food is not problematic in terms of containing nutritional components, it is a so-called "health food" and cannot be expected to be effective in improving disease conditions.

本発明は、上記のごとき問題点を解決した、いわゆる病
態改善効果と、これを補強する栄養補充効果とを兼備し
た発酵食品を提供することを目的としている。
An object of the present invention is to provide a fermented food that solves the above-mentioned problems and has both a so-called disease-improving effect and a nutritional supplementing effect to reinforce this effect.

(問題点を解決するための手段) 上記の目的を達成した本発明の発酵食品は、マンネンタ
ケ属に属する担子菌と、穀類またはイモ類と、豆類とよ
り成り、β−〇−グルカンと大豆サポニンとエルゴステ
ロールとを含有することを特徴としている。
(Means for Solving the Problems) The fermented food of the present invention that achieves the above objects is composed of basidiomycetes belonging to the genus Stonebush, grains or tubers, and beans, and contains β-〇-glucan and soybean saponin. and ergosterol.

本発明者らは、従来の「特殊栄養食品」、「医療用食品
」、「健康食品」に見られる種々の問題点を考慮し、栄
養成分にのみ注視したり、植物・動物性原料から抽出し
て得られる有効成分を含有するエキスを混合したりして
「健康食品」とするのではなく、新たに病態改善用食品
を得ることを目的として開発を行なh1々ンネンタケ属
に属する担子菌と、穀−またはイモ類と、豆類とより成
す、β−D−fルカンとサポニンとエルゴステロールと
を含有する発酵食品を発明するに至った。
The inventors of the present invention have taken into account various problems found in conventional "special nutritional foods,""medicalfoods," and "health foods," and have focused only on nutritional components, extracted from plant and animal raw materials, etc. Rather than mixing the extract containing the active ingredients obtained from the process to create a "health food", we developed it with the aim of obtaining a new food for improving disease conditions. The inventors have now invented a fermented food containing β-D-f lucan, saponin, and ergosterol, which is made from grains or potatoes, and beans.

本発明の発酵食品は、蛋白質、炭水化物をはじめとする
各種栄養成分もバランスよく含有しており、病態改善効
果とも合わせて、「特殊栄養食品」、「医療用食品」と
することもできる。
The fermented food of the present invention also contains various nutritional components such as proteins and carbohydrates in a well-balanced manner, and can also be used as a "special nutritional food" or "medical food" due to its ability to improve pathological conditions.

マンネンタケ属の担子菌は、古くから身体に有用である
ことが知られ、特に最近、高血圧などにも効くというこ
とが知られてきた。
The basidiomycete of the genus Cynthia has been known for a long time to be useful for the body, and in particular, it has recently been known that it is also effective against high blood pressure.

本発明において使用するマ、ンネンタケ属の担子菌は、
例えば、マンネンタケ、マゴジャクシ、ツガノマンネン
タケ、シママンネンタケ等の担子菌の菌糸体であり、好
ましくはマンネンタケの繭糸体を使用する。
The basidiomycetes of the genus Matriculum used in the present invention are
For example, the mycelium of basidiomycetes such as C. chinensis, C. chinensis, C. chinensis, and C. chinensis is used, and preferably cocoon bodies of C. chinensis are used.

本発明の発酵食品は、炭素源として穀類またはイモ類、
窒素源として豆類を用いた培地に、マンネンタケ属に属
する担子菌を培養することにより得られる。
The fermented food of the present invention uses grains or potatoes as a carbon source,
It is obtained by culturing a basidiomycete belonging to the genus Hemorrhoids in a medium using beans as a nitrogen source.

培地成分である穀類とイモ類と豆類は、通常の食品とし
て利用される食品群(日本標準食品成分表〔科学技術庁
資源調査会編〕に記載の食品群)より選ぶことにより、
最終的に得られる培養物を分離・抽出の操作を経なくて
も、そのままで可食の状態とすることができる。また、
分離・抽出等の操作を加えなくてもよいために、可食成
分の持つ豊富な炭水化物や蛋白質等が生体にとって吸収
されやすい物質に変化し、栄養成分が損われることなく
残存している。
Grains, potatoes, and beans, which are the culture medium components, are selected from food groups commonly used as food (food groups listed in the Japan Standard Food Composition Table [edited by the Science and Technology Agency Resources Investigation Committee]).
The finally obtained culture can be made edible as it is without undergoing separation and extraction operations. Also,
Since there is no need to perform operations such as separation and extraction, the rich carbohydrates and proteins contained in the edible components are converted into substances that are easily absorbed by the body, and the nutritional components remain intact.

穀類としては、玄米、精白米等の米、生そば、そば粉、
とうもろこし、あわ、えんばく、おおむぎ等を使用し、
好ましくは各種形態の米、そば粉を使用する。イモ類と
しては、さつまいも、じゃがいも、さといも、長芋等を
使用し、好ましくはさつまいもを使用する。豆類として
は、大豆あるいは脱脂大豆、きな粉なEの大豆製品等を
使用し、好ましくは大豆を使用する。
Grains include rice such as brown rice and polished rice, raw buckwheat, buckwheat flour,
Using corn, millet, oats, oats, etc.
Preferably, various forms of rice and buckwheat flour are used. As the potatoes, sweet potatoes, potatoes, taro, Japanese yam, etc. are used, and sweet potatoes are preferably used. As the beans, soybeans, defatted soybeans, soybean products such as Soybean flour E, etc. are used, and soybeans are preferably used.

また、この可食培地は、穀類またはイモ類と豆類だけで
もよいが、グルコース、硫酸マグネシウム(食品添加物
用)、リン酸−カリウム(食品添加物用)を加えてもよ
い。しかし、可食成分以外のものは含まない。
Further, this edible medium may contain only cereals or potatoes and beans, but glucose, magnesium sulfate (for food additives), and potassium phosphate (for food additives) may also be added. However, it does not contain anything other than edible ingredients.

マンネンタケ属の担子菌をこの可食培地を用いて培養す
ることによって、本発明の発酵食品が得られる。
The fermented food of the present invention can be obtained by culturing the basidiomycete of the genus Hemorrhoid using this edible medium.

この発酵食品は、次のすべての特性を有する。This fermented food has all the following properties:

1)制癌作用等の薬理効果を持つβ−D−グルカンを、
乾燥粉末状態で0.05〜10f/100f−粉末含有
する。このβ−D−グルカンは分岐鎖を持つβ−(1,
5)−p−グルカンであり、平均分子量は約108万で
ある。
1) β-D-glucan, which has pharmacological effects such as anticancer effect,
Contains 0.05-10f/100f-powder in dry powder state. This β-D-glucan has a branched chain β-(1,
5) -p-glucan, with an average molecular weight of about 1,080,000.

2)抗補体活性作用、抗酸化作用等の薬理効果を有する
大豆サポニン等のサポニンを、乾燥粉末状態で0.05
〜3f/1005’−粉末含有する。
2) Saponin such as soybean saponin, which has pharmacological effects such as anti-complement activity and antioxidant effect, is added in dry powder form at 0.05%.
~3f/1005'- Contains powder.

5)利未効果等の薬理幼果を有するエルゴステロール金
、乾燥粉末状態で1.0へ100.G〜71009−粉
末含有する。
5) Ergosterol gold with pharmacological immature effects such as Rimi effect, dry powder state from 1.0 to 100. G~71009- Contains powder.

本発明の発酵食品は、例えば、以下のような操作で製造
することができる。
The fermented food of the present invention can be produced, for example, by the following operations.

炭水化物を多量に含む穀類またはイモ類の少なくとも一
種からなる炭素源と、蛋白質を多量和合む豆類からなる
窒素源とを含有する可食成分のみで構成された培地で、
マンネンタケ属の担子菌の菌糸体の液体培養を行なう。
A medium consisting only of edible ingredients, including a carbon source consisting of at least one type of grain or tuber that contains a large amount of carbohydrates, and a nitrogen source consisting of legumes that are compatible with a large amount of protein.
A liquid culture of basidiomycete mycelium of the genus C. chinensis is carried out.

培養条件は、培養温度を51〜45C1培養液pHを2
.5〜5.5培地1tあたり通気量を0.5〜2.Ot
/Has種菌接檻量を0.5〜20%とすることにより
、4へ15日間で培養できる。このようにして得られた
発酵生産物は、培養終了後の可食培地と菌糸体および菌
糸体生成物を培養液から分離しないで、その−ままでも
本発明の発酵食品として利用できる。または脱水のみの
加工を施して、有用成分を可能な限り多く含む発酵食品
とすることもできる。
The culture conditions are: culture temperature: 51-45C, culture solution pH: 2
.. 5-5.5 Aeration amount per 1 ton of medium 0.5-2. Ot
/Has inoculum inoculation amount is 0.5 to 20%, it is possible to culture in 4 to 15 days. The fermented product thus obtained can be used as it is as the fermented food of the present invention without separating the edible medium, mycelium, and mycelial product from the culture solution after completion of the culture. Alternatively, fermented foods containing as much useful ingredients as possible can be produced by processing only dehydration.

本発明の発酵食品の高血圧者用としての摂取適tは、年
齢、個人差、症状などに影響されるので、場合によって
は下記範囲外の量が適量となることもあるが、粉末を水
または熱水、牛乳等に懸濁して摂取する場合、1日あた
り粉末20へ30ofを、粉末1fあたり5〜10−の
水または熱水、牛乳等に1@濁して、1回から3回に分
けて5ケ月以上飲用することが好ましい。   ′(発
明の効果) 本発明の発酵食品に、少なくともβ−D−グルカンとサ
ポニンとエルゴステロールという31道ffiの薬理効
果を持つ有効成分を含有しており、少なくともマンネン
タケ属の担子菌の子実体に期待されると同程度以上の病
態改善効果を与える。例えば、血液の動態を改善するこ
とによる高血圧、心臓疾患、脳血管障害等に対する病態
改善効果である。他にも利1求効果や新陳代謝の促進等
も期待できる。
The appropriate intake amount of the fermented food of the present invention for people with high blood pressure is affected by age, individual differences, symptoms, etc. Depending on the case, the appropriate amount may be outside the range below, but the powder may be mixed with water or When ingesting by suspending in hot water, milk, etc., take 20 to 30 of the powder per 1 f of the powder, suspending it in 5 to 10 - of water or hot water, milk, etc., and dividing it into 1 to 3 doses per day. It is preferable to drink it for 5 months or more. (Effects of the Invention) The fermented food of the present invention contains at least β-D-glucan, saponin, and ergosterol, which are active ingredients having 31 pharmacological effects, and at least the fruiting bodies of Basidiomycetes of the genus Hemorrhoids. It has the same or better effect on improving the condition as expected. For example, it has an effect of improving blood pressure, heart disease, cerebrovascular disorder, etc. by improving blood dynamics. It can also be expected to have a benefit-seeking effect and promote metabolism.

また、担子菌と可食培地により、蛋白質、炭水化物をは
じめとする各種栄養成分もバランスよく含まれており、
病者用食品としての利用価値の高いものになっており、
病態改善効果と合わせて「特殊栄養食品」や「医療用食
品」としても適したものである。
In addition, the basidiomycetes and edible medium contain a well-balanced variety of nutritional components including proteins and carbohydrates.
It has high utility value as food for the sick,
In addition to its ability to improve pathological conditions, it is also suitable as a ``special nutritional food'' or ``medical food.''

さらに、医学的・栄養学的見地からみて、特別の栄養的
配慮を必要とする病者や、病態改善を目的とする場合の
みでなく、各種疾病の予防、食生活改善、健康維持、体
力向上の目的で用いることもでき、利用対象者が広範囲
である。
Furthermore, from a medical and nutritional standpoint, it is not only used for sick patients who require special nutritional consideration or for the purpose of improving disease conditions, but also for preventing various diseases, improving dietary habits, maintaining health, and improving physical strength. It can also be used for this purpose, and can be used by a wide range of people.

マンネンタケの子実体やそのエキスでは、マンネンタケ
特有の強い苦味を有しており、通常の食品としては利用
しえない欠点があるが、本発明の発酵食品は、わずかな
嗜好性のある苦味を有して訃す、かつ培地成分である食
品材料が持っている風味も損うことなくとどめているの
で、食品として適したものである。
The fruiting bodies and extracts of C. chinensis have a strong bitter taste that is unique to M. chinensis and cannot be used as regular foods, but the fermented food of the present invention has a slightly palatable bitter taste. It is suitable as a food because it retains the flavor of the food material, which is a culture medium component, without losing its flavor.

また−1本発明の発酵食品を液体培養により得る場合に
は、製造条件を一定に保つことができ、薬理効果のある
有効成分および栄養成分の安定した品質のものが得られ
る。
In addition, -1, when the fermented food of the present invention is obtained by liquid culture, the manufacturing conditions can be kept constant, and products with stable quality of pharmacologically effective active ingredients and nutritional ingredients can be obtained.

(実施例) 以下に実施例を示すが、本発明は、この実施例により限
定されるものではない。
(Example) Examples are shown below, but the present invention is not limited to these examples.

また、試験例1.2に示すように、マンネンタケ属の担
子菌の菌糸体を、穀類またはイモ類と豆類とを構成要素
とする培地を用いて培養することだより、得られる本発
明の発酵食品に含有される蛋白質および糖質も、構成4
素の穀類またはイモ類と豆類とマンネンタケ属の担子菌
とをただ単に混合した場合に比べて、消化・吸収されや
すい形の遊離アミノ酸および単砧に分解されており、消
化能力の衰えた病者に適した食品となることがわかる。
In addition, as shown in Test Example 1.2, the fermentation of the present invention obtained by culturing the mycelium of Basidiomycetes of the genus Stonebush using a medium containing grains or potatoes and beans as constituents. Proteins and carbohydrates contained in foods are also component 4.
Compared to a simple mixture of raw grains or potatoes, legumes, and basidiomycetes of the genus Stonefish, it is broken down into free amino acids and monokin that are easier to digest and absorb, and can be used by sick people with weakened digestive abilities. It can be seen that it is a food suitable for

実施例 試験発酵格を用いて、マンネンタケ菌糸体の培養を次の
とおり行なつ几。
EXAMPLE Test Using a fermentation container, the cultivation of Cinnamon mycelium was carried out as follows.

1ooz容の試験発#偕中で第1表に示しfc可食培地
成分を水40tに溶解し、pHを4.0に調整し、12
0C2気圧で30分殺菌した。同じ組成の回文培地で3
2C,4日間振盪培養して得友a菌糸培養UfIJ1.
6tを接種した。培養温度を32Cに保ち、7日間通気
(、aot/am)a拌(200r、p、m、)培誉す
ると、粘調な培養物が得られた。
FC edible medium components shown in Table 1 were dissolved in 40 t of water in a 1 oz volume of test formulation, the pH was adjusted to 4.0, and 12
It was sterilized for 30 minutes at 0C and 2 atmospheres. 3 with a palindromic medium of the same composition.
2C, cultured with shaking for 4 days to obtain a mycelial culture UfIJ1.
6t was inoculated. A viscous culture was obtained by maintaining the culture temperature at 32 C and culturing with aeration (, aot/am) and agitation (200 r, p, m,) for 7 days.

これt−04L結乾脈し、粉末1.5 kgを得た。こ
の粉末は、されやかな風味とほのかな苦味を有し、食品
として適しtものであり、かつ81!2表に示すような
栄養成分および有効成分を含んでhた。なお、β−D−
グルカンと大豆サポニンはガスクロマトグラフィーによ
シ、エルゴステロールは高速液体クロマトグラフィーに
より定量を行なり九。
This t-04L was dried to obtain 1.5 kg of powder. This powder had a mild flavor and a slight bitterness, was suitable as a food, and contained nutritional ingredients and active ingredients as shown in Table 81!2. In addition, β-D-
Glucan and soybean saponin were determined by gas chromatography, and ergosterol was determined by high performance liquid chromatography.

この粉末の急性毒性1ddYマウス(雄)5週令を用い
て調べたが%経口投与可能な最大量である5000In
9/ゆ一体型の投与系でも1体重推移、一般症状の観察
において異常は認められなかった。
The acute toxicity of this powder was investigated using 1ddY mice (male) 5 weeks old, and the maximum dose that can be administered orally was 5000In.
Even with the 9/Yu one-type administration system, no abnormalities were observed in the body weight transition and observation of general symptoms.

このe末syに0.5%カルボキシメチルセルロース溶
it 00tdを加え、自然発症高血圧ラット(SHR
)に300ダ一粉末/kg一体重の割合で経口投与した
ところ、図面に示すような血圧降下作用を示した。[飢
この粉末30fK水200−を加えた粘調な液体を2回
/日×3ケ月飲用すると、高血圧患者に改善がみられ友
。投与前後の平均血圧の差を降圧度判定基準にし友がい
5段階別血圧降下の程度として第3表に示した。
0.5% carboxymethyl cellulose dissolved it 00td was added to this e-terminal SY, and spontaneously hypertensive rats (SHR) were added.
) was orally administered at a rate of 300 powder per kg per body weight, it exhibited a blood pressure lowering effect as shown in the figure. [When drinking a viscous liquid containing 30 fK of starch powder and 200 fK of water twice a day for 3 months, patients with high blood pressure showed improvement. The difference in mean blood pressure before and after administration was used as the criterion for determining the degree of blood pressure reduction, and the degree of blood pressure reduction was shown in Table 3 according to five levels.

第1表 第2表 試験例1 マンネンタケ属の担子菌の菌糸体培養を行なうことによ
って、培地成分である可食成分のうち蛋白質がどのよう
に変化しているかを調べる之めに。
Table 1 Table 2 Test Example 1 To investigate how proteins among the edible components of the medium were changed by culturing the mycelia of Basidiomycetes of the genus Stone.

下記の試験を行なった。The following tests were conducted.

大豆(全粒のまま)302を500−三°角フラスコに
入れ、グルコース3.0%、硫酸マグネシウム0.1%
、リン酸−カリウム0.1チの組成の溶液30−を加え
、120C2気圧で20分殺菌する。
Put 302 soybeans (whole grains) into a 500-degree Erlenmeyer flask, add 3.0% glucose and 0.1% magnesium sulfate.
, a solution 30- of potassium phosphate-0.1% was added and sterilized at 120C and 2 atm for 20 minutes.

この1ま菌糸体を加えずに、32Cで7日間静置した後
、遠心分離により上溝のみ金得る。これ全試料Iとする
After leaving the mixture for 7 days at 32C without adding mycelium, the upper groove was obtained by centrifugation. This is referred to as total sample I.

同様に大豆(全粒のまま) 50 fft500m!三
角フラスコに入れ、グルコース3.Ol、硫酸マグネシ
ウム0.1%、リン酸−カリウム0.1 %の組成の溶
液30a!!’i加え、120c2気圧で20分殺菌す
る。32Cまで冷却後、水洗によシ培地成分を取シ除い
たマンネンタケ培養菌糸体の極IMを8% (v/v 
)加える。32Cで7日間静置培養し友後、遠心分離に
上り上清のみを得る。これを試料■とする。
Similarly, soybeans (whole grains) 50 fft500m! Pour glucose into an Erlenmeyer flask.3. Solution 30a with a composition of Ol, magnesium sulfate 0.1%, and potassium phosphate 0.1%! ! 'i and sterilize for 20 minutes at 120C 2 atm. After cooling to 32C, 8% (v/v
) add. After standing and culturing at 32C for 7 days, centrifugation is performed to obtain only the supernatant. This is designated as sample (■).

試料Iと試料■について溶液中の遊離アミノ酸1rσ1
り足したところ、試料■の方が各アミノ酸とも増加して
いることがわかった。すなわち、マンネンタケ菌糸体分
混在させることにより、培地中の蛋白質が消化・吸収さ
れやすい形の遊離アミノ酸に分解されていることがわか
った。その結果を第4表に示す。
Free amino acids 1rσ1 in solution for sample I and sample
When the amounts were added up, it was found that each amino acid was higher in sample (■). In other words, it was found that by mixing the M. chinensis mycelium, proteins in the medium were decomposed into free amino acids that were easily digested and absorbed. The results are shown in Table 4.

第  4  表    単位: mti/売試験例2 7ンネンタケ属の担子菌の菌糸体培養を行なうことによ
って、培地成分である可食成分のうち糖質がどのように
変化しているかを調べるために。
Table 4 Unit: mti/sales Test Example 2 7 To investigate how carbohydrates among the edible components of the medium have changed by culturing the mycelia of basidiomycetes of the genus P. chinensis.

下記の試験を行なつ九。Perform the following tests.9.

デンプン5慢、コーン・ステイープ・リカー2−1硫酸
マグネシウム0.1%、  リン酸−カリウム0.1%
の成分組成で培地を作成し、pHを4.0に調整後、こ
の溶液10011dを500−坂ロフラスコに入れ、1
2QC2気圧で20分殺菌する。32Cまで冷却後、水
洗によって培地成分を取り除いたマンネンタケ培養菌糸
体を種菌として4%(V/V)加え%S2C:c8日間
振盪培養する。培養開始前と培養終了後の液から遠心分
離によシ上清のみ金得て、試料■および試料■とする。
Starch 5, Corn Steep Liquor 2-1 Magnesium Sulfate 0.1%, Potassium Phosphate 0.1%
After preparing a medium with the component composition and adjusting the pH to 4.0, put this solution 10011d into a 500-Sakaro flask,
Sterilize at 2QC 2 atm for 20 minutes. After cooling to 32C, 4% (V/V) of the cultured mycelium of C. chinensis from which medium components were removed by washing with water was added as a seed fungus, and cultured with shaking at %S2C:c for 8 days. Only the supernatant was obtained by centrifugation from the liquid before the start of culture and after the end of culture, and used as sample ① and sample ②.

試料■と試料■について、溶液中の単糖とオリゴ糖の量
を測定したところ、試料出に比べて試料■では単糖が増
加していることがわかった。すなわち、マンネンタケ菌
糸体を混在させることにより、培地中の多糖が消化・吸
収されやすい形の単(ノ1に分解されていることがわか
った。その結果を第5表に示す。
When the amounts of monosaccharides and oligosaccharides in the solution were measured for sample (2) and sample (2), it was found that the amount of monosaccharide was increased in sample (2) compared to the sample sample. In other words, it was found that by mixing the Bamboo shoots mycelium, the polysaccharide in the medium was decomposed into a form that is easily digested and absorbed.Table 5 shows the results.

第5表 単位:’?/diTable 5 unit:'? /di

【図面の簡単な説明】[Brief explanation of drawings]

図面は実施例において得られた製品の経口投与による血
圧降下作用を示す図表である。
The figure is a chart showing the blood pressure lowering effect of oral administration of the products obtained in the Examples.

Claims (1)

【特許請求の範囲】[Claims] マンネンタケ属に属する担子菌と、穀類またはイモ類と
、豆類とより成り、β−D−グルカンと、サポニンと、
エルゴステロールとを含有することを特徴とする発酵食
品。
Consisting of basidiomycetes belonging to the genus Bamboo shoots, grains or tubers, and beans, β-D-glucan, saponin,
A fermented food characterized by containing ergosterol.
JP60284211A 1985-12-19 1985-12-19 Fermented food Pending JPS62145027A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60284211A JPS62145027A (en) 1985-12-19 1985-12-19 Fermented food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60284211A JPS62145027A (en) 1985-12-19 1985-12-19 Fermented food

Publications (1)

Publication Number Publication Date
JPS62145027A true JPS62145027A (en) 1987-06-29

Family

ID=17675601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60284211A Pending JPS62145027A (en) 1985-12-19 1985-12-19 Fermented food

Country Status (1)

Country Link
JP (1) JPS62145027A (en)

Similar Documents

Publication Publication Date Title
US20040043056A1 (en) Diet composition comprising raw foods and dietary fibers
CN103271158B (en) Health preserving cereal milk and preparation method thereof
KR20040063690A (en) Functional liquor
CN101455363A (en) Health-care food or health-care food additive containing oxygen-derived free radicals scavenger
CN108813535A (en) A kind of vegetarian diet chicken flavor flavoring compositions, steamed bean curd roll powder and preparation method
KR20040063699A (en) Functional leg bone broth
JPS62145027A (en) Fermented food
KR20040063693A (en) Functional milk product
JPS62234028A (en) Food for patient of diabetes
KR20040063695A (en) Functional feed
JPS62234025A (en) Food for senile dementia
JPS62234027A (en) Food for patient of hyperlipemia
JPS62234026A (en) Food for patient of hepatic function disorder
KR20040069591A (en) Functional soybean milk
JPS63181960A (en) Processed and unpolished rice
JPS62224283A (en) Saponin-containing mycelium
KR20040063709A (en) Functional mixed grain powder
KR20040063713A (en) Functional pickled food products
KR20040064909A (en) Functional salted food product
KR20040063700A (en) Functional boiled fish paste
KR20040063681A (en) Functional kimchi
CN115444017A (en) Low-calorie composite nutritional meal replacement biscuit containing olive mushrooms and preparation method of biscuit
KR20040063696A (en) Functional noodles
KR20040063705A (en) Functional chewing gum
KR20040063707A (en) Functional processed fish products